BMP7 Expression Correlates with Secondary Drug Resistance in Mantle Cell Lymphoma

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Camara Clayette, Valérie ^a,b   Koscielny, Serge ^a   Roux, Sébastien ^a,b   Lamy, Thierry ^c,d   Bosq, Jacques ^a   Bernard, Marc ^c   Fest, Thierry ^c,d   Lazar, Vladimir ^a   Lenoir, Gilbert ^a   Ribrag, Vincent ^a,b  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b INSERM   (France)

^c RENNES UNIVERSITY HOSPITAL   (France)

^d UNIVERSITÉ DE RENNES 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BORTEZOMIB; CYTARABINE; MESSENGER RNA; OSTEOGENIC PROTEIN 1;

ADULT; AGED; APOPTOSIS; ARTICLE; BMP7 GENE; CANCER CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MANTLE CELL LYMPHOMA;

ADULT; AGED; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BASE SEQUENCE; BONE MORPHOGENETIC PROTEIN 7; BORONIC ACIDS; CELL LINE, TUMOR; CPG ISLANDS; DNA METHYLATION; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHOMA, MANTLE-CELL; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NEOPLASM STAGING; PYRAZINES; RECURRENCE; RNA INTERFERENCE; TREATMENT OUTCOME;

EID: 84884189499     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0073993     Document Type: Article

References (24)

1. Ghielmini M, Zucca E, (2009) How I treat mantle cell lymphoma. Blood 114: 1469-1476. doi:10.1182/blood-2009-02-179739. PubMed: 19556426.
2. Goy A, Kahl B, (2011) Mantle cell lymphoma: the promise of new treatment options. Crit Rev Oncol/Hematol 80: 69-86. doi:10.1016/j.critrevonc.2010.09.003. PubMed: 21168343.
3. Leonard JP, Williams ME, Goy A, Grant S, Pfreundschuh M, et al. (2009) Mantle cell lymphoma: biological insights and treatment advances. Clin Lymphoma Myeloma 9: 267-277. doi:10.3816/CLM.2009.n.055. PubMed: 19717376.
4. Michiels S, Koscielny S, Hill C, (2005) Prediction of cancer outcome with microarrays: a multiple random validation strategy. Lancet 365: 488-492. doi:10.1016/S0140-6736(05)17866-0. PubMed: 15705458.
5. Gomez-Roca CA, Lacroix L, Massard C, De Baere T, Deschamps F, et al. (2012) Sequential research-related biopsies in phase I trials: acceptance, feasibility and safety. Ann Oncol 23: 1301-1306. doi:10.1093/annonc/mdr383. PubMed: 21917737.
6. Hogan BL, (1996) Bone morphogenetic proteins in development. Curr Opin Genet Dev 6: 432-438. doi:10.1016/S0959-437X(96)80064-5. PubMed: 8791534.
7. Miyazono K, Maeda S, Imamura T, (2005) BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk. Cytokine Growth Factor Rev 16: 251-263. doi:10.1016/j.cytogfr.2005.01.009. PubMed: 15871923.
8. Tamaki K, Souchelnytskyi S, Itoh S, Nakao A, Sampath K, et al. (1998) Intracellular signaling of osteogenic protein-1 through Smad5 activation. J Cell Physiol 177: 355-363. doi:10.1002/(SICI)1097-4652(199811)177:2. PubMed: 9766532.
9. Zwijsen A, Verschueren K, Huylebroeck D, (2003) New intracellular components of bone morphogenetic protein/Smad signaling cascades. FEBS Lett 546: 133-139. doi:10.1016/S0014-5793(03)00566-0. PubMed: 12829249.
10. Beck SE, Carethers JM, (2007) BMP suppresses PTEN expression via RAS/ERK signaling. Cancer Biol Ther 6: 1313-1317. PubMed: 18059158.
11. Hu MC, Wasserman D, Hartwig S, Rosenblum ND, (2004) p38MAPK acts in the BMP7-dependent stimulatory pathway during epithelial cell morphogenesis and is regulated by Smad1. J Biol Chem 279: 12051-12059. PubMed: 14718543.
12. Yang S, Lim M, Pham LK, Kendall SE, Reddi AH, et al. (2006) Bone morphogenetic protein 7 protects prostate cancer cells from stress-induced apoptosis via both Smad and c-Jun NH2-terminal kinase pathways. Cancer Res 66: 4285-4290. doi:10.1158/0008-5472.CAN-05-4456. PubMed: 16618753.
13. Alarmo EL, Pärssinen J, Ketolainen JM, Savinainen K, Karhu R, et al. (2009) BMP7 influences proliferation, migration, and invasion of breast cancer cells. Cancer Lett 275: 35-43. doi:10.1016/j.canlet.2008.09.028. PubMed: 18980801.
14. Aoki M, Ishigami S, Uenosono Y, Arigami T, Uchikado Y, et al. (2011) Expression of BMP-7 in human gastric cancer and its clinical significance. Br J Cancer 104: 714-718. doi:10.1038/sj.bjc.6606075. PubMed: 21224856.
15. Motoyama K, Tanaka F, Kosaka Y, Mimori K, Uetake H, et al. (2008) Clinical significance of BMP7 in human colorectal cancer. Ann Surg Oncol 15: 1530-1537. doi:10.1245/s10434-007-9746-4. PubMed: 18259822.
16. Rothhammer T, Poser I, Soncin F, Bataille F, Moser M, et al. (2005) Bone morphogenic proteins are overexpressed in malignant melanoma and promote cell invasion and migration. Cancer Res 65: 448-456. PubMed: 15695386.
17. Sunde JS, Donninger H, Wu K, Johnson ME, Pestell RG, et al. (2006) Expression profiling identifies altered expression of genes that contribute to the inhibition of transforming growth factor-beta signaling in ovarian cancer. Cancer Res 66: 8404-8412. doi:10.1158/0008-5472.CAN-06-0683. PubMed: 16951150.
18. Yang S, Pham LK, Liao CP, Frenkel B, Reddi AH, et al. (2008) A novel bone morphogenetic protein signaling in heterotypic cell interactions in prostate cancer. Cancer Res 68: 198-205. doi:10.1158/0008-5472.CAN-07-5074. PubMed: 18172312.
19. Huse K, Bakkebø M, Wälchli S, Oksvold MP, Hilden VI, et al. (2012) Role of Smad proteins in resistance to BMP-induced growth inhibition in B-cell lymphoma. PLOS ONE 7: e46117. doi:10.1371/journal.pone.0046117. PubMed: 23049692.
20. Grcević D, Kusec R, Kovacić N, Lukić A, Lukić IK, et al. (2010) Bone morphogenetic proteins and receptors are over-expressed in bone-marrow cells of multiple myeloma patients and support myeloma cells by inducing ID genes. Leuk Res 34: 742-751. doi:10.1016/j.leukres.2009.10.016. PubMed: 19926132.
21. Huse K, Bakkebø M, Oksvold MP, Forfang L, Hilden VI, et al. (2011) Bone morphogenetic proteins inhibit CD40L/IL-21-induced Ig production in human B cells: differential effects of BMP-6 and BMP-7. Eur J Immunol 41: 3135-3145. doi:10.1002/eji.201141558. PubMed: 21898381.
22. Rothhammer T, Wild PJ, Meyer S, Bataille F, Pauer A, et al. (2007) Bone morphogenetic protein 7 (BMP7) expression is a potential novel prognostic marker for recurrence in patients with primary melanoma. Cancer Biomark 3: 111-117. PubMed: 17522432.
23. Kron K, Pethe V, Briollais L, Sadikovic B, Ozcelik H, et al. (2009) Discovery of novel hypermethylated genes in prostate cancer using genomic CpG island microarrays. PLOS ONE 4: e4830. doi:10.1371/journal.pone.0004830. PubMed: 19283074.
24. Yamashita S, Tsujino Y, Moriguchi K, Tatematsu M, Ushijima T, (2006) Chemical genomic screening for methylation-silenced genes in gastric cancer cell lines using 5-aza-2'-deoxycytidine treatment and oligonucleotide microarray. Cancer Sci 97: 64-71. doi:10.1111/j.1349-7006.2006.00136.x. PubMed: 16367923.